CASE REPORT
Published on 02 May 2025
Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion
doi 10.3389/fonc.2025.1481602
- 547 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Biomarker Discovery and Therapeutic Innovations in Genito-Urinary Cancer Management
Biomarker Discovery and Therapeutic Innovations in Genito-Urinary Cancer Management
3,722
Total downloads
13k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Published on 17 Mar 2025
Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1554048
- 1,209 views
MINI REVIEW
Published on 15 Jan 2025
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
doi 10.3389/fonc.2024.1457006
- 1,002 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Development and external validation of a model to predict recurrence in patients with non-muscle invasive bladder cancer
doi 10.3389/fimmu.2024.1467527
- 1,067 views
ORIGINAL RESEARCH
Published on 07 Jan 2025
Single-cell transcriptomics reveals the heterogeneity and function of mast cells in human ccRCC
doi 10.3389/fimmu.2024.1494025
- 1,722 views
- 1 citation
CASE REPORT
Published on 18 Dec 2024
Toripalimab plus chemotherapy for metastatic muscle-invasive bladder cancer with a high tumor proportion score: a case report
doi 10.3389/fimmu.2024.1485744
- 730 views
REVIEW
Published on 13 Nov 2024
The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets
doi 10.3389/fimmu.2024.1464327
- 1,103 views
- 2 citations
ORIGINAL RESEARCH
Published on 28 Oct 2024
Hypofractionated radiotherapy with simultaneous integrated boost for localized prostate cancer patients: effects on immune system and prediction of toxicity
doi 10.3389/fimmu.2024.1457839
- 1,001 views
ORIGINAL RESEARCH
Published on 10 May 2024
Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma
doi 10.3389/fimmu.2024.1401214
- 1,281 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: